Shih-Cheng Wu

Dr. Shih-Cheng Wu

National Health Research Institutes
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
SWShih-Cheng Wu
Shih-Cheng Wu
ZCZih-Syuan Cao
Zih-Syuan Cao
KCKuo-Ming Chang
Kuo-Ming Chang
AJand Jyh-Lyh Juang
and Jyh-Lyh Juang
Neuroinflammation caused by local deposits of Aβ42 in the brain is key for the pathogenesis and progression of Alzheimer’s disease. However, inflammation in the brain is not always a response to local primary insults. Gut microbiota dysbiosis, which is recently emerging as a risk factor for psychiatric disorders, can also initiate a brain inflammatory response. It still remains unclear however, whether enteric dysbiosis also contributes to Alzheimer’s disease. Here we show that in a Drosophila Alzheimer’s disease model, enterobacteria infection exacerbated progression of Alzheimer’s disease by promoting immune hemocyte recruitment to the brain, thereby provoking TNF-JNK mediated neurodegeneration. Genetic depletion of hemocytes attenuates neuroinflammation and alleviated neurodegeneration. We further found that enteric infection increases the motility of the hemocytes, making them more readily attracted to the brain with an elevated oxidative stress status. This work highlights the importance of gut–brain crosstalk as a fundamental regulatory system in modulating Alzheimer’s disease neurodegeneration.

1 April 2012 in Cell Host & Microbe
Verified
Journal Article
Closed access
SWShih-Cheng Wu
Shih-Cheng Wu
CLChih-Wei Liao
Chih-Wei Liao
RPRong-Long Pan
Rong-Long Pan
JJJyh-Lyh Juang
Jyh-Lyh Juang

20 September 2008 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
YYYu-Jen Yu
Yu-Jen Yu
SWShih-Cheng Wu
Shih-Cheng Wu
HCHung-Hsiang Chan
Hung-Hsiang Chan
YCYu-Cheng Chen
Yu-Cheng Chen
YCYuzong Chen
Yuzong Chen
MYMing-Te Yang
Ming-Te Yang

22 July 2023 in EBioMedicine
Verified
Journal Article
Open access
HLHsing-Han Li
Hsing-Han Li
MSMatthew P. Su
Matthew P. Su
SWShih-Cheng Wu
Shih-Cheng Wu
HTHsiao-Hui Tsou
Hsiao-Hui Tsou
MCMeng-Chun Chang
Meng-Chun Chang
CCChun-Hong Chen
Chun-Hong Chen
Dengue virus outbreaks are increasing in number and severity worldwide. Viral transmission is assumed to require a minimum time period of viral replication within the mosquito midgut. It is unknown if alternative transmission periods not requiring replication are possible. We used a mouse model of dengue virus transmission to investigate the potential of mechanical transmission of dengue virus. We investigated minimal viral titres necessary for development of symptoms in bitten mice and used resulting parameters to inform a new model of dengue virus transmission within a susceptible population. Naïve mice bitten by mosquitoes immediately after they took partial blood meals from dengue infected mice showed symptoms of dengue virus, followed by mortality. Incorporation of mechanical transmission into mathematical models of dengue virus transmission suggest that this supplemental transmission route could result in larger outbreaks which peak sooner. The potential of dengue transmission routes independent of midgut viral replication has implications for vector control strategies that target mosquito lifespan and suggest the possibility of similar mechanical transmission routes in other disease-carrying mosquitoes. This study was funded by grants from the National Health Research Institutes, Taiwan (04D2-MMMOST02), the 10.13039/100004412 Human Frontier Science Program (RGP0033/2021), the 10.13039/100000002 National Institutes of Health (1R01AI143698-01A1, R01AI151004 and DP2AI152071) and the 10.13039/501100004663 Ministry of Science and Technology, Taiwan (MOST104-2321-B-400-016).

9 March 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LCLie Cheng
Lie Cheng
WLWei-Liang Liu
Wei-Liang Liu
YTYun-Ting Tsou
Yun-Ting Tsou
JLJian-Chiuan Li
Jian-Chiuan Li
CCChia-Hao Chien
Chia-Hao Chien
CCChun-Hong Chen
Chun-Hong Chen
The C-type lectins, one family of lectins featuring carbohydrate binding domains which participate in a variety of bioprocesses in both humans and mosquitoes, including immune response, are known to target DENV. A human C-type lectin protein CLEC18A in particular shows extensive glycan binding abilities and correlates with type-I interferon expression, making CLEC18A a potential player in innate immune responses to DENV infection; this potential may provide additional regulatory point in improving mosquito immunity. Here, we established for the first time a transgenic Aedes aegypti line that expresses human CLEC18A. This expression enhanced the Toll immune pathway responses to DENV infection. Furthermore, viral genome and virus titers were reduced by 70% in the midgut of transgenic mosquitoes. We found significant changes in the composition of the midgut microbiome in CLEC18A expressing mosquitoes, which may result from the Toll pathway enhancement and contribute to DENV inhibition. Transgenic mosquito lines offer a compelling option for studying DENV pathogenesis, and our analyses indicate that modifying the mosquito immune system via expression of a human immune gene can significantly reduce DENV infection.

1 January 2020 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
HTHui-Ying Tsai
Hui-Ying Tsai
SWShih-Cheng Wu
Shih-Cheng Wu
JLJian-Chiuan Li
Jian-Chiuan Li
YCYu-Min Chen
Yu-Min Chen
CCChih-Chiang Chan
Chih-Chiang Chan
CCChun-Hong Chen
Chun-Hong Chen
Maple syrup urine disease (MSUD) is an inherited error in the metabolism of branched-chain amino acids (BCAAs) caused by a severe deficiency of the branched-chain α-ketoacid dehydrogenase (BCKDH) complex, which ultimately leads to neurological disorders. The limited therapies, including protein-restricted diets and liver transplants, are not as effective as they could be for the treatment of MSUD due to the current lack of molecular insights into the disease pathogenesis. To address this issue, we developed a Drosophila model of MSUD by knocking out the dDBT gene, an ortholog of the human gene encoding the dihydrolipoamide branched chain transacylase (DBT) subunit of BCKDH. The homozygous dDBT mutant larvae recapitulate an array of MSUD phenotypes, including aberrant BCAA accumulation, developmental defects, poor mobile behavior and disrupted L-glutamate homeostasis. Moreover, the dDBT mutation causes neuronal apoptosis during the developmental progression of larval brains. The genetic and functional evidence generated by in vivo depletion of dDBT expression in the eye indicates severe impairment of retinal rhabdomeres. Further, the dDBT mutant shows elevated oxidative stress and higher lipid peroxidation accumulation in the larval brain. Therefore, we conclude from in vivo evidence that the loss of dDBT results in oxidative brain damage that may lead to neuronal cell death and contribute to aspects of MSUD pathology. Importantly, when the dDBT mutants were administrated with Metformin, the aberrances in BCAA levels and motor behavior were ameliorated. This intriguing outcome strongly merits the use of the dDBT mutant as a platform for developing MSUD therapies. This article has an associated First Person interview with the joint first authors of the paper.